Author

Anna L. K. Gonye

Broad InstituteORCID 0000-0003-0034-1756Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Irena GushterovaiD· 2 shared Moshe Sade-FeldmaniD· 2 shared Nir HacoheniD· 2 shared Thomas James LaSalleiD· 2 shared Alexandra–Chloé VillaniiD· 1 shared Alexis M. SchneideriD· 1 shared Amanda S. ZajaciD· 1 shared Anat O Stemmer-RachamimoviD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Irena GushterovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsCell Reports MedicinePeer-reviewedFeb 1, 2022

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim…·Nir Hacohen

The paper develops DNA- and RNA-based models combining immune and tumor features to predict outcomes of checkpoint inhibition in melanoma.

38 citations

humanwhole-exome sequencing

𝕏 PostBluesky

Systems BiologyCell Reports MedicinePeer-reviewedMay 1, 2021

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients

Michael R. Filbin, Arnav Mehta, Alexis M. Schneider…·Marcia B. Goldberg

The paper uses plasma proteomics to identify tissue-specific cell death and cell-cell interaction mediators in severe COVID-19 patients, linking them to survival outcomes and viral infection effects.

313 citationstop 1%

humanproteomics

𝕏 PostBluesky